|
FR2556219B1
(fr)
|
1983-12-07 |
1987-06-26 |
Merieux Inst |
Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
|
|
US5426641A
(en)
|
1994-01-28 |
1995-06-20 |
Bell Communications Research, Inc. |
Adaptive class AB amplifier for TDMA wireless communications systems
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
CA2257861A1
(en)
|
1996-06-14 |
1997-12-18 |
Smithkline Beecham Corporation |
Hexameric fusion proteins and uses therefor
|
|
US20090074839A1
(en)
|
1997-01-22 |
2009-03-19 |
Marton Milankovits |
Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications
|
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US7951917B1
(en)
|
1997-05-02 |
2011-05-31 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
EP1240337B1
(en)
|
1999-12-24 |
2006-08-23 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20050089932A1
(en)
|
2001-04-26 |
2005-04-28 |
Avidia Research Institute |
Novel proteins with targeted binding
|
|
EP1697520A2
(en)
|
2003-12-22 |
2006-09-06 |
Xencor, Inc. |
Fc polypeptides with novel fc ligand binding sites
|
|
AU2006232287B2
(en)
|
2005-03-31 |
2011-10-06 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for producing polypeptides by regulating polypeptide association
|
|
GB0614780D0
(en)
|
2006-07-25 |
2006-09-06 |
Ucb Sa |
Biological products
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
BRPI0620639A2
(pt)
|
2006-12-21 |
2011-11-22 |
Micromet Ag |
anticorpos de cadeia simples biespecìficos e composição farmacêutica compreendendo os mesmos
|
|
EP2144930A1
(en)
|
2007-04-18 |
2010-01-20 |
ZymoGenetics, Inc. |
Single chain fc, methods of making and methods of treatment
|
|
EP2158318A2
(en)
|
2007-05-14 |
2010-03-03 |
Biogen Idec MA, Inc. |
Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
|
|
PL2185589T3
(pl)
|
2007-06-01 |
2016-09-30 |
|
Środki wiążące receptor regionu stałego Fc immunoglobuliny
|
|
JP6157046B2
(ja)
|
2008-01-07 |
2017-07-05 |
アムジェン インコーポレイテッド |
静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法
|
|
WO2009123894A2
(en)
*
|
2008-04-02 |
2009-10-08 |
Macrogenics, Inc. |
Her2/neu-specific antibodies and methods of using same
|
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
|
WO2010065578A2
(en)
|
2008-12-04 |
2010-06-10 |
Leukosight Inc. |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
|
|
US10865233B2
(en)
|
2008-12-18 |
2020-12-15 |
Dana-Farber Cancer Institute, Inc. |
NKG2D-fc for immunotherapy
|
|
JP2012515556A
(ja)
|
2009-01-23 |
2012-07-12 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
低下したエフェクタ機能を有する安定化Ｆｃポリペプチドおよび使用方法
|
|
EP2432803A2
(en)
|
2009-05-20 |
2012-03-28 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
EP2432451A2
(en)
|
2009-05-20 |
2012-03-28 |
Children's Medical Center Corporation |
Compositions for the treatment of metastatic cancer and methods of use thereof
|
|
CN102549016B
(zh)
|
2009-06-30 |
2015-05-06 |
研究发展基金会 |
免疫球蛋白fc多肽
|
|
EP2478013B1
(en)
|
2009-09-16 |
2018-10-24 |
F.Hoffmann-La Roche Ag |
Coiled coil and/or tether containing protein complexes and uses thereof
|
|
JP5898082B2
(ja)
|
2009-10-07 |
2016-04-06 |
マクロジェニクス，インコーポレーテッド |
フコシル化程度の変更により改良されたエフェクター機能を示すＦｃ領域含有ポリペプチドおよびその使用法
|
|
MX340971B
(es)
|
2009-11-23 |
2016-08-02 |
Amgen Inc * |
Fragmento cristalizable (fc) de anticuerpo monomerico.
|
|
GB0922209D0
(en)
|
2009-12-18 |
2010-02-03 |
Univ Nottingham |
Proteins, nucleic acid molecules and compositions
|
|
EP2571992B1
(en)
|
2010-05-21 |
2018-04-25 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins
|
|
TW201217527A
(en)
|
2010-07-09 |
2012-05-01 |
Biogen Idec Hemophilia Inc |
Processable single chain molecules and polypeptides made using same
|
|
TWI542597B
(zh)
|
2010-07-28 |
2016-07-21 |
吉林尼克公司 |
產生依序多聚體化免疫球蛋白ｆｃ組合物之天然人類蛋白質片段之融合蛋白
|
|
JP2013537416A
(ja)
|
2010-08-13 |
2013-10-03 |
メディミューン リミテッド |
変異型Ｆｃ領域を含むモノマーポリペプチド及び使用方法
|
|
ES2758994T3
(es)
|
2010-11-05 |
2020-05-07 |
Zymeworks Inc |
Diseño anticuerpo heterodimérico estable con mutaciones en el dominio Fc
|
|
IN2013MN01438A
(https=)
|
2011-03-17 |
2015-06-12 |
Univ Ramot |
|
|
BR112013023918A2
(pt)
|
2011-03-25 |
2016-12-13 |
Glenmark Pharmaceuticals Sa |
imunoglobulina hetero-dimérica ou fragmento hetero-dimérico da mesma, método para produzir uma imunoglobulina hetero-dimérica ou fragmento hetero-dimérico da mesma, método para construir uma interface proteína-proteína de um domínio de uma proteína de múltiplos domínios e uso de um domínio doador de um primeiro e de um segundo membro de uma super-família de imunoglobulina de ocorrência natural
|
|
WO2013185113A1
(en)
|
2012-06-08 |
2013-12-12 |
Biogen Idec Ma Inc. |
Procoagulant compounds
|
|
HK1209034A1
(en)
|
2012-06-21 |
2016-03-24 |
Indiana University Research And Technology Corporation |
Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function
|
|
US9683044B2
(en)
*
|
2012-08-20 |
2017-06-20 |
Gliknik Inc. |
Molecules with antigen binding and polyvalent FC gamma receptor binding activity
|
|
BR112015008663B1
(pt)
*
|
2012-10-17 |
2021-01-12 |
CSL Behring Lengnau AG |
Uso de uma quantidade eficaz de uma proteína polimérica compreendendo seis unidades demonômero de polipeptídeo
|
|
CN104558194B
(zh)
|
2013-10-17 |
2018-04-27 |
泰州迈博太科药业有限公司 |
一类抗CD20-Flex双功能融合蛋白、其制备方法及用途
|
|
JP2016538283A
(ja)
*
|
2013-11-13 |
2016-12-08 |
ザイムワークス，インコーポレイテッド |
Ｅｇｆｒ及び／またはｈｅｒ２を標的にする一価抗原結合性構築物及びその使用
|
|
EP3082847A1
(en)
|
2013-12-20 |
2016-10-26 |
Indiana University Research and Technology Corporation |
Lipidated incretin receptor ligand human immunoglobulin fc-region fusion polypeptides
|
|
CN113248613B
(zh)
|
2014-01-15 |
2024-08-23 |
豪夫迈·罗氏有限公司 |
具有修饰的FCRN结合性质的Fc区变体
|
|
RU2727639C2
(ru)
*
|
2014-01-15 |
2020-07-22 |
Ф.Хоффманн-Ля Рош Аг |
Варианты fc-области с модифицированной способностью связываться с fcrn и с сохраненной способностью связываться с белком а
|
|
CA2939201A1
(en)
|
2014-03-05 |
2015-09-11 |
Ucb Biopharma Sprl |
Multimeric fc proteins
|
|
MX2016010951A
(es)
|
2014-03-05 |
2016-11-29 |
Ucb Biopharma Sprl |
Proteinas de fc multimericas.
|
|
CA2945882A1
(en)
|
2014-04-16 |
2015-10-22 |
Ucb Biopharma Sprl |
Multimeric fc proteins
|
|
EP4299595A3
(en)
*
|
2014-05-02 |
2024-03-13 |
Momenta Pharmaceuticals, Inc. |
Compositions and methods related to engineered fc constructs
|
|
EA035419B9
(ru)
|
2014-05-29 |
2020-08-07 |
Мэкроудженикс, Инк. |
Триспецифичные связывающие молекулы и способы их применения
|
|
EP3423572B1
(en)
*
|
2016-03-02 |
2023-11-29 |
Momenta Pharmaceuticals, Inc. |
Methods related to engineered fc constructs
|
|
DK3484514T3
(da)
|
2016-05-23 |
2024-01-29 |
Momenta Pharmaceuticals Inc |
Compositions and methods related to engineered fc constructs
|
|
JP7146771B2
(ja)
|
2017-01-06 |
2022-10-04 |
モメンタ ファーマシューティカルズ インコーポレイテッド |
操作されたＦｃコンストラクトに関する組成物及び方法
|